Related Experiment Video
Updated: Mar 14, 2026

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
Lysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications
Maria do Carmo de Freire Bastos1, Bruna Gonçalves Coutinho2, Marcus Lívio Varella Coelho3
1Departamento de Microbiologia Geral, Instituto de Microbiologia Prof. Paulo de Góes, CCS, Bloco I, UFRJ, 21941-590, Rio de Janeiro, RJ, Brazil. mcbastos@micro.ufrj.br.
Lysostaphin, a unique bacteriocin, effectively lyses staphylococcal pathogens. This antimicrobial agent shows promise for treating staphylococcal infections in both clinical and community settings.
Area of Science:
- Microbiology
- Biochemistry
- Pharmacology
Background:
- Staphylococcal infections pose a significant global health challenge.
- Bacteriocins, including staphylococcins, are antimicrobial peptides with bactericidal properties.
- Lysostaphin is a unique Class III staphylococcin with potent antistaphylococcal activity.
Approach:
- Investigated the bacteriolytic activity of lysostaphin against staphylococcal pathogens.
- Evaluated the potential of lysostaphin as a therapeutic agent for staphylococcal infections.
- Reviewed in vitro and in vivo studies on lysostaphin's efficacy.
Key Points:
- Lysostaphin exhibits high bacteriolytic activity specifically against staphylococci.
- It is inactive against other bacterial genera, indicating specificity.
- Lysostaphin production is a bacterial self-protection mechanism.
Conclusions:
- Lysostaphin demonstrates significant potential for biotechnological applications in treating staphylococcal infections.
- It can be used alone or in combination with other antimicrobials.
- Further research supports its use in preventing and treating staphylococcal diseases.
Related Concept Videos
Lytic Cycle of Bacteriophages
Special Staining Techniques

